Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C16H30O6 |
| Molecular Weight | 318.4058 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 5 / 5 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCCCCCO[C@H]1[C@H](O[C@@H]2OC(C)(C)O[C@H]12)[C@H](O)CO
InChI
InChIKey=GWSUUEYOBZZHIJ-UXXRCYHCSA-N
InChI=1S/C16H30O6/c1-4-5-6-7-8-9-19-13-12(11(18)10-17)20-15-14(13)21-16(2,3)22-15/h11-15,17-18H,4-10H2,1-3H3/t11-,12-,13+,14-,15-/m1/s1
DescriptionSources: https://adisinsight.springer.com/drugs/800003766
Sources: https://adisinsight.springer.com/drugs/800003766
Seprilose is a carbohydrate compound that inhibits prostaglandin E2 synthesis. Seprilose was undergoing phase II trials with Boston Life Sciences in the USA for the treatment of Rheumatic disorders, but this development was discontinued.
Originator
Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C344
Created by
admin on Mon Mar 31 18:05:45 GMT 2025 , Edited by admin on Mon Mar 31 18:05:45 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
60818
Created by
admin on Mon Mar 31 18:05:45 GMT 2025 , Edited by admin on Mon Mar 31 18:05:45 GMT 2025
|
PRIMARY | |||
|
C152339
Created by
admin on Mon Mar 31 18:05:45 GMT 2025 , Edited by admin on Mon Mar 31 18:05:45 GMT 2025
|
PRIMARY | |||
|
7268
Created by
admin on Mon Mar 31 18:05:45 GMT 2025 , Edited by admin on Mon Mar 31 18:05:45 GMT 2025
|
PRIMARY | |||
|
CHEMBL2107533
Created by
admin on Mon Mar 31 18:05:45 GMT 2025 , Edited by admin on Mon Mar 31 18:05:45 GMT 2025
|
PRIMARY | |||
|
5764EUK72N
Created by
admin on Mon Mar 31 18:05:45 GMT 2025 , Edited by admin on Mon Mar 31 18:05:45 GMT 2025
|
PRIMARY | |||
|
FF-29
Created by
admin on Mon Mar 31 18:05:45 GMT 2025 , Edited by admin on Mon Mar 31 18:05:45 GMT 2025
|
PRIMARY | |||
|
SUB10486MIG
Created by
admin on Mon Mar 31 18:05:45 GMT 2025 , Edited by admin on Mon Mar 31 18:05:45 GMT 2025
|
PRIMARY | |||
|
DTXSID90158322
Created by
admin on Mon Mar 31 18:05:45 GMT 2025 , Edited by admin on Mon Mar 31 18:05:45 GMT 2025
|
PRIMARY | |||
|
100000084133
Created by
admin on Mon Mar 31 18:05:45 GMT 2025 , Edited by admin on Mon Mar 31 18:05:45 GMT 2025
|
PRIMARY | |||
|
133692-55-4
Created by
admin on Mon Mar 31 18:05:45 GMT 2025 , Edited by admin on Mon Mar 31 18:05:45 GMT 2025
|
PRIMARY |
ACTIVE MOIETY